Beckman Coulter Life Sciences announced a strategic partnership to integrate its liquid‑handling and cell‑analysis instruments with Automata’s LINQ AI‑ready automation platform, aiming to deliver scalable, connected lab automation for AI‑driven R&D. Danaher Ventures joined Automata’s Series C and will take a board seat as part of the collaboration. Automata also closed a $45 million Series C that included the Danaher strategic investment. The combined moves signal increased industry investment in modular lab automation and data infrastructure to generate high‑quality datasets for machine‑assisted discovery.